Maximizing the potential public health impact of HPV vaccines: a focus on parents.
Kahn
Jessica A
JA
D000293:Adolescent; D001294:Attitude to Health; D002648:Child; D005260:Female; D006293:Health Promotion / Q000379:methods*; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control* / Q000523:psychology; D053918:Papillomavirus Vaccines; D010290:Parents / Q000523:psychology*; D010342:Patient Acceptance of Health Care / Q000523:psychology; D012749:Sexually Transmitted Diseases / Q000517:prevention & control / Q000523:psychology; D014481:United States
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18